Patrys and Garvan Institute of Medical Research Awarded Grant

Patrys Limited (ASX: PAB), a clinical stage biotechnology company and Sydney’s Garvan Institute of Medical Research (Garvan) have recently finalized the terms of a Federal Government Innovation Connections grant to support research within the PATDX1 program. The Garvan is one of Australian’s leading biomedical research institutes.

The research will be undertaken by Dr Marina Pajic, Leader in the Personalised Cancer Therapeutics Laboratory. Since 2013, Dr Pajic has been driving research to develop novel clinically relevant tailored treatment strategies for pancreatic cancer through collaborative Australian Pancreatic Cancer Genome Initiative (APGI) studies at Garvan as part of the International Cancer Genome Consortium sequencing effort. Dr Pajic has established unique research tools for studying pancreatic cancer.

The Innovation Connections grant of $50,000 will be used to determine the efficacy of PAT-DX1 in in vitro studies of pancreatic cancer cell lines, and selected well-characterised pancreatic cancer models both as a single agent and in combination with therapies commonly used in this space.

“This is the first time we have collaborated with Garvan and we are very pleased to establish a relationship with Dr Pajic and her expert team. The collaboration should provide data regarding the
potential effectiveness of PAT-DX1 as a treatment for pancreatic cancer, which has the highest mortality rate of all major cancers,” said Dr James Campbell, Chief Executive Officer and Managing
Director of Patrys. “The Federal Government’s Innovation Connections scheme plays a critical role in nurturing partnerships between Australian based companies and the research sector.”

Dr Marina Pajic said, “We are enthusiastic to work with Patrys to investigate the utility of PAT-DX1 in pancreatic cancer. The Innovation Connections grant program is supporting exciting innovative technology with the potential for improving patient outcomes.”

Patrys expects to be able to report on the research findings in 2018.

Innovation Connection Program

The Federal Government’s Innovation Connections program provides small and medium sized businesses with support to collaborate with the research sector in developing new ideas with
commercial potential.

About the Garvan Institute of Medical Research

The Garvan Institute of Medical Research is one of Australia’s largest medical research institutes. Garvan’s main research areas are: cancer, diabetes and metabolism, genomics and epigenetics,
immunology and inflammation, osteoporosis and bone biology, and neuroscience. Garvan’s mission is to make significant contributions to medical science that will change the directions of science and medicine and have major impacts on human health.

Further information and source here

About Patrys Limited:

Based in Melbourne, Australia, Patrys (ASX: PAB) is focused on the development of antibodies as therapies for a range of different cancers. Patrys has a pipeline of anti-cancer antibodies for both internal development and as partnering opportunities. More information can be found at


News & opinion

Member Directory